#10465
Mentioned in 5 episodes

Malignant

How Bad Policy and Bad Evidence Harm People with Cancer
Book • 2020
In 'Malignant', Dr. Vinayak K. Prasad critiques the current state of oncology, highlighting issues such as lax regulatory standards, financial conflicts of interest, and the overemphasis on surrogate endpoints in clinical trials.

He argues for reforms to ensure that cancer drugs provide meaningful benefits at lower costs.

The book offers insights into how cancer trials are conducted and how drugs are approved, proposing solutions to improve cancer medicine.

Mentioned by

Mentioned in 5 episodes

Mentioned by Bari Weiss as the author of the book, highlighting his expertise in the field.
73 snips
Will Ozempic Solve Obesity in America? A Debate
Mentioned by Bob Kaplan as a book he is currently reading, focusing on public health policy and cancer.
20 snips
#103 - Looking back on the first 99 episodes: Strong Convictions, Loosely Held
Mentioned by Vinay Prasad as the book that discusses the state of cancer research and pharmaceuticals.
12 snips
Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
Mentioned by Russ Roberts in the introduction, referencing Dr. Vinay Prasad 's previous appearance on the show.
Vinay Prasad on the Pandemic
Mentioned by Peter Attia as Vinay Prasad 's book published this year, focusing on oncology.
#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy
Mentioned by Russ Roberts as the subject of the EconTalk episode and author of the book.
Vinay Prasad on Cancer Drugs, Medical Ethics, and Malignant

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app